As per the devised categorical rating system, patients were given 1 point each for maximal tumor diameter at baseline CT > 20 mm, preoperative CA 19-9 levels > 150 U/mL, and KRAS G12 mutation dosage based on TS data > 0.195. The gene discussed is KRAS; the disease is neoplasm.